BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 3484631)

  • 1. Demonstration of anaphylatoxins C3a, C4a and C5a in the scales of psoriasis and inflammatory pustular dermatoses.
    Takematsu H; Ohkohchi K; Tagami H
    Br J Dermatol; 1986 Jan; 114(1):1-6. PubMed ID: 3484631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C3, C5 components and C3a, C4a, and C5a fragments of the complement system.
    Janatova J
    Methods Enzymol; 1988; 162():579-625. PubMed ID: 3265757
    [No Abstract]   [Full Text] [Related]  

  • 3. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
    Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
    Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis and leukocyte chemotaxis.
    Tagami H; Iwatsuki K; Takematsu H
    J Invest Dermatol; 1987 Mar; 88(3 Suppl):18s-23s. PubMed ID: 3493302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaphylatoxin levels in human aqueous humor.
    Mondino BJ; Sumner H
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of three separate anaphylatoxins from complement-activated human serum.
    Hugli TE; Gerard C; Kawahara M; Scheetz ME; Barton R; Briggs S; Koppel G; Russell S
    Mol Cell Biochem; 1981 Dec; 41():59-66. PubMed ID: 6977086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of anaphylatoxin concentrations in suction blisters in patients with psoriasis.
    Ohkohchi K; Takematsu H; Tagami H
    J Invest Dermatol; 1986 Jul; 87(1):65-7. PubMed ID: 3487596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased anaphylatoxins (C3a and C4a) in psoriatic sera.
    Ohkohchi K; Takematsu H; Tagami H
    Br J Dermatol; 1985 Aug; 113(2):189-96. PubMed ID: 3875363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaphylatoxin generation in multisystem organ failure.
    Heideman M; Hugli TE
    J Trauma; 1984 Dec; 24(12):1038-43. PubMed ID: 6334754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemistry and biology of anaphylatoxins.
    Hugli TE
    Complement; 1986; 3(3):111-27. PubMed ID: 3542363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of leukotriene B4 in the scale extracts of psoriasis and inflammatory pustular dermatoses. Correlation with leukocyte chemotactic activity and C5a anaphylatoxin.
    Takematsu H; Terui T; Tagami H
    Acta Derm Venereol; 1986; 66(1):6-10. PubMed ID: 2424218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ; Das C; Bennett D; Terman DS
    J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis.
    Hack CE; Nuijens JH; Felt-Bersma RJ; Schreuder WO; Eerenberg-Belmer AJ; Paardekooper J; Bronsveld W; Thijs LG
    Am J Med; 1989 Jan; 86(1):20-6. PubMed ID: 2783358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative structural anatomy of the complement anaphylatoxin proteins C3a, C4a and C5a.
    Greer J
    Enzyme; 1986; 36(1-2):150-63. PubMed ID: 3491754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of complement in psoriasis and atopic dermatitis--measurement of C3a and C5a, C3, C4 and C1 inactivator.
    Kapp A; Wokalek H; Schöpf E
    Arch Dermatol Res; 1985; 277(5):359-61. PubMed ID: 3875319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation.
    Nagata S; Glovsky MM
    J Allergy Clin Immunol; 1987 Jul; 80(1):24-32. PubMed ID: 3496373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma anaphylatoxin concentrations in inflammatory skin diseases.
    Terui T; Takematsu H; Kato T; Ohkohchi K; Tagami H
    Tohoku J Exp Med; 1987 Feb; 151(2):245-52. PubMed ID: 3495048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation produced by biomaterials.
    Chenoweth DE
    Artif Organs; 1988 Dec; 12(6):508-10. PubMed ID: 3265053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
    Meuer S; Hugli TE; Andreatta RH; Hadding U; Bitter-Suermann D
    Inflammation; 1981 Dec; 5(4):263-73. PubMed ID: 6976935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
    Schifferli JA; Steiger G; Paccaud JP
    Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.